A randomised, parallel-group clinical trial comparing bedinvetmab to meloxicam for the management of canine osteoarthritis

A randomised, parallel-group clinical trial comparing bedinvetmab to meloxicam for the management of canine osteoarthritis

Bedinvetmab (Librela®), a fully canine anti-nerve growth factor monoclonal antibody, was compared to the non-steroidal anti-inflammatory drug (NSAID) meloxicam in dogs for the management of osteoarthritis-related pain in a randomised, open-label, multicentre, parallel-group study. Subjects were recr...

Full description

Saved in:

Bibliographic Details
Main Authors:	John F. Innes, B. Duncan X. Lascelles, Daniel Bell, Robert Tulloch, Alex McVey, Chad Northcott, Mahala Welbourn, Kate Higgins, Veronika Horakova, Thomas W. Maddox
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-03-01
Series:	Frontiers in Veterinary Science
Subjects:	bedinvetmab meloxicam canine orthopaedic index canine osteoarthritis degenerative joint disease monoclonal antibody
Online Access:	https://www.frontiersin.org/articles/10.3389/fvets.2025.1502218/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Global pharmacovigilance reporting of the first monoclonal antibody for canine osteoarthritis: a case study with bedinvetmab (Librela™)
by: Beatriz P. Monteiro, et al.
Published: (2025-04-01)

Factors influencing, and associated with, physical activity patterns in dogs with osteoarthritis-associated pain
by: Christina Stevens, et al.
Published: (2025-03-01)

Musculoskeletal adverse events in dogs receiving bedinvetmab (Librela)
by: Mike Farrell, et al.
Published: (2025-05-01)

Commentary: Musculoskeletal adverse events in dogs receiving bedinvetmab (Librela)
by: Matthew Warren Brunke, et al.
Published: (2025-07-01)

Ice water immersion does not activate diffuse noxious inhibitory controls of spinal reflexes in sedated or anaesthetised dogs (Canis familiaris): a pilot study
by: J. R. Hunt, et al.
Published: (2025-03-01)

Proteomic profiling of serum in cats with naturally occurring degenerative joint disease and co-morbid conditions
by: B. Duncan X. Lascelles, et al.
Published: (2025-02-01)

Diagnostic Imaging in the Degenerative Diseases of the Spine in Dogs
by: Dženita HADŽIJUNUZOVIĆ-ALAGIĆ, et al.
Published: (2024-11-01)

MELOXICAM: USE PROSPECTS IN ERYTHEMA NODOSUM
by: O N Egorova, et al.
Published: (2010-03-01)

Effect of Meloxicam and Nano-meloxicam on selected haematological and immunological parameters in arthritis-induced male albino rats
by: Adel Bashar, et al.
Published: (2025-06-01)

Echocardiographic Changes in Dogs with Stage B2 Myxomatous Mitral Valve Disease Treated with Pimobendan Monotherapy
by: Andrew Crosland, et al.
Published: (2024-11-01)

USE OF INJECTABLE MELOXICAM (AMELOTEX®) FORMULATION IN PATIENTS WITH GONARTHROSIS
by: M S Eliseyev, et al.
Published: (2009-09-01)

Use of meloxicam (Amelotex®) in patients with chronic gout to prevent
by: M S Eliseyev, et al.
Published: (2011-12-01)

Evaluation of cognitive and mobility function in geriatric dogs following treatment with stem cell and stem cell extracellular vesicles derived from embryonic stem cells: a pilot study
by: Tae-Yoon Kim, et al.
Published: (2025-03-01)

Genotypic and Allelic Frequencies of Degenerative Myelopathy in an Italian Canine Population
by: Sara Ghilardi, et al.
Published: (2024-09-01)

Migration of a Mature Transmigrated Canine: Literature Review and a Case Report
by: Mayur Bhola, et al.
Published: (2025-01-01)

Effect of meloxicam on serum vitamin and cytokine levels during endotoxemia
by: Akile Ozlem Yurt

Use of meloxicam (amelotex®) in patients with gonarthrosis
by: Maksim Sergeevich Eliseev, et al.
Published: (2011-06-01)

Melox (meloxicam) clinical efficacy in chronic joint diseases
by: Sh Erdes, et al.
Published: (2003-08-01)

Pentoxifylline in Dogs With Osteoarthritis: Comparative Treatment and Efficacy Analysis With Meloxicam
by: Kurtuluş Parlak, et al.
Published: (2025-07-01)

PROGNOSIS OF RETENTION AND ABNORMAL POSITION OF CANINES
by: S.I. Doroshenko, et al.
Published: (2020-09-01)

Meloxicam (movalis) in a physician's practice
by: Yuliya Leonidovna Korsakova, et al.
Published: (2011-09-01)

Effect of repeated administration of diclofenac sodium and meloxicam on coagulation parameters in sheep
by: Ramazan Yıldız, et al.

Pharmacoeconomic analysis of the use of movalis (meloxicam) in patients with nonspecific back pain
by: O. N. Gerasimova, et al.
Published: (2011-12-01)

Evaluation of Bacillus subtilis ATCC PTA-122264 on the fecal characteristics and microbiota of healthy adult dogs subjected to an abrupt diet change
by: Patrícia M. Oba, et al.
Published: (2025-07-01)

Use of meloxicam (Amelotex®) in patients with pyrophosphate arthropathy
by: Maksim Sergeevich Eliseev, et al.
Published: (2011-09-01)

DETERMINATION OF MELOXICAM IN TABLETS BY THIRD DERIVATIVE UV SPECTROPHOTOMETRIC METHOD
by: Zeynep Aydoğmuş, et al.
Published: (2024-02-01)

Amantadine as a therapeutic option for neuropathic pain in dogs with degenerative lumbosacral stenosis
by: Chiara Caterino, et al.
Published: (2025-07-01)

Local therapy of the knee osteoarthritis: results of a multicenter study of meloxicam
by: N. V. Toroptsova, et al.
Published: (2023-07-01)

Impact of Formulation Variables on Meloxicam spanlastics Preparation
by: Lubna Sabri, et al.
Published: (2024-12-01)

Eco-friendly four spectrophotometric approaches for the simultaneous determination of the recently FDA-approved combination, bupivacaine and meloxicam in pharmaceutical dosage forms
by: Aya Saad Radwan, et al.
Published: (2024-11-01)

Spectrophotometric determination of meloxicam in medicinal products
by: S. O. Vasyuk, et al.
Published: (2025-07-01)

General medical aspects of the use of meloxicam (Movalis®) in clinical practice: Efficacy and safety
by: Natalia Vladimirovna Chichasova
Published: (2012-12-01)

Dissolution Enhancement of Meloxicam Tablets from the Synergistic Effect of Hydrotropic and Sublimating Agent
by: Hemn L. Qader, et al.
Published: (2021-12-01)

MELOXICAM: WHAT DO WE KNOW ABOUT CARDIOVASCULAR SAFETY?
by: M S Eliseev, et al.
Published: (2010-03-01)

A cost-effective and sensitive TLC-densitometric identification of meloxicam
by: Parys Wioletta, et al.
Published: (2021-03-01)

Pharmacokinetics of Meloxicam in Different Animal Species: A Comprehensive Review
by: Raul de la Puente, et al.
Published: (2024-10-01)

A Novel Case Report of Impacted Mandibular Canine with Bifid Roots
by: Pallavi Raina, et al.
Published: (2020-07-01)

Attitudes of Australian Veterinary Professionals to Diagnosing and Managing Canine Cognitive Dysfunction
by: Auréa Brisset, et al.
Published: (2025-03-01)

An old friend: 25 years of meloxicam use in Russia.
by: A. E. Karateev, et al.
Published: (2021-07-01)

Recognizing and Mitigating Canine Stress in Human–Canine Interaction Research: Proposed Guidelines
by: Simone B. Sidel, et al.
Published: (2025-06-01)